Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 506)
Posted On: 01/24/2022 11:49:37 AM
Post# of 154722
Posted By: sean007
Re: chazzledazzle #115837
TAM 37 Million worldwide...Hiv-1 infections. Therapeutics targeting CCR5 generally involve gene-editing techniques including CRISPR, CCR5 blockade using antibodies or antagonists, or a combination of both.

Ohm20/and others...does our Vyrologix prevent the ongoing establishment of LATENT HIV-1 reservoirs of the monoclonals directed at CCR5 that have been investigated.
(LL) Vyrologix has achieved the best-sustained receptor occupancy thus far.

Cardozo-Ojeda et al. developed a mathematical model that projects the minimum threshold of CCR5 edited cells necessary to achieve a functional cure for HIV-1 infection.













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site